{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:22Z","timestamp":1793332462046,"version":"4.5.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1007\/s12035-015-9106-5","type":"journal-article","created":{"date-parts":[[2015,1,30]],"date-time":"2015-01-30T19:57:36Z","timestamp":1422647856000},"page":"1494-1500","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":85,"title":["Serum MicroRNA Signatures in Migraineurs During Attacks and in Pain-Free Periods"],"prefix":"10.1007","volume":"53","author":[{"given":"Hjalte H.","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg","family":"Duroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parisa","family":"Gazerani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,2,1]]},"reference":[{"key":"9106_CR1","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s10194-005-0252-4","volume":"6","author":"M Leonardi","year":"2005","unstructured":"Leonardi M, Steiner TJ, Scher AT, Lipton RB (2005) The global burden of migraine: measuring disability in headache disorders with WHO\u2019s Classification of Functioning, Disability and Health (ICF). J Headache Pain 6:429\u2013440. doi: 10.1007\/s10194-005-0252-4","journal-title":"J Headache Pain"},{"key":"9106_CR2","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1146\/annurev-physiol-030212-183717","volume":"75","author":"D Pietrobon","year":"2013","unstructured":"Pietrobon D, Moskowitz MA (2013) Pathophysiology of migraine. Annu Rev Physiol 75:365\u2013391. doi: 10.1146\/annurev-physiol-030212-183717","journal-title":"Annu Rev Physiol"},{"key":"9106_CR3","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.pharmthera.2009.09.003","volume":"124","author":"CM Villal\u00f3n","year":"2009","unstructured":"Villal\u00f3n CM, Olesen J (2009) The role of CGRP in the pathophysiology of migraine and efficacy of CGRP receptor antagonists as acute antimigraine drugs. Pharmacol Ther 124:309\u2013323. doi: 10.1016\/j.pharmthera.2009.09.003","journal-title":"Pharmacol Ther"},{"key":"9106_CR4","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1111\/head.12174","volume":"53","author":"P Durham","year":"2013","unstructured":"Durham P, Papapetropoulos S (2013) Biomarkers associated with migraine and their potential role in migraine management. Headache 53:1262\u20131277. doi: 10.1111\/head.12174","journal-title":"Headache"},{"key":"9106_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1042\/CS20130203","volume":"126","author":"KC Vickers","year":"2014","unstructured":"Vickers KC, Rye K-A, Tabet F (2014) microRNAs in the onset and development of cardiovascular disease. Clin Sci (Lond) 126:183\u2013194. doi: 10.1042\/CS20130203","journal-title":"Clin Sci (Lond)"},{"key":"9106_CR6","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s12035-012-8349-7","volume":"47","author":"HG M\u00f8ller","year":"2013","unstructured":"M\u00f8ller HG, Rasmussen AP, Andersen HH et al (2013) A systematic review of microRNA in glioblastoma multiforme: micro-modulators in the mesenchymal mode of migration and invasion. Mol Neurobiol 47:131\u2013144. doi: 10.1007\/s12035-012-8349-7","journal-title":"Mol Neurobiol"},{"key":"9106_CR7","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/ncb0309-228","volume":"11","author":"J Winter","year":"2009","unstructured":"Winter J, Jung S, Keller S et al (2009) Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol 11:228\u2013234. doi: 10.1038\/ncb0309-228","journal-title":"Nat Cell Biol"},{"key":"9106_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.nbd.2014.08.003","volume":"71","author":"HH Andersen","year":"2014","unstructured":"Andersen HH, Duroux M, Gazerani P (2014) MicroRNAs as modulators and biomarkers of inflammatory and neuropathic pain conditions. Neurobiol Dis 71:159\u2013168. doi: 10.1016\/j.nbd.2014.08.003","journal-title":"Neurobiol Dis"},{"key":"9106_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1744-8069-3-15","volume":"3","author":"G Bai","year":"2007","unstructured":"Bai G, Ambalavanar R, Wei D, Dessem D (2007) Downregulation of selective microRNAs in trigeminal ganglion neurons following inflammatory muscle pain. Mol Pain 3:15. doi: 10.1186\/1744-8069-3-15","journal-title":"Mol Pain"},{"key":"9106_CR10","doi-asserted-by":"crossref","unstructured":"Bali KK, Kuner R (2014) Noncoding RNAs: key molecules in understanding and treating pain. Trends Mol Med 1\u201312. doi: 10.1016\/j.molmed.2014.05.006","DOI":"10.1016\/j.molmed.2014.05.006"},{"key":"9106_CR11","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1186\/1479-5876-9-195","volume":"9","author":"IA Orlova","year":"2011","unstructured":"Orlova IA, Alexander GM, Qureshi RA et al (2011) MicroRNA modulation in complex regional pain syndrome. J Transl Med 9:195. doi: 10.1186\/1479-5876-9-195","journal-title":"J Transl Med"},{"key":"9106_CR12","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/1744-8069-8-17","volume":"8","author":"M Chattopadhyay","year":"2012","unstructured":"Chattopadhyay M, Zhou Z, Hao S et al (2012) Reduction of voltage gated sodium channel protein in DRG by vector mediated miRNA reduces pain in rats with painful diabetic neuropathy. Mol Pain 8:17. doi: 10.1186\/1744-8069-8-17","journal-title":"Mol Pain"},{"key":"9106_CR13","doi-asserted-by":"publisher","first-page":"e78762","DOI":"10.1371\/journal.pone.0078762","volume":"8","author":"JL Bjersing","year":"2013","unstructured":"Bjersing JL, Lundborg C, Bokarewa MI, Mannerkorpi K (2013) Profile of cerebrospinal microRNAs in fibromyalgia. PLoS One 8:e78762. doi: 10.1371\/journal.pone.0078762","journal-title":"PLoS One"},{"key":"9106_CR14","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-014-3139-3","author":"JL Bjersing","year":"2014","unstructured":"Bjersing JL, Bokarewa MI, Mannerkorpi K (2014) Profile of circulating microRNAs in fibromyalgia and their relation to symptom severity: an exploratory study. Rheumatol Int. doi: 10.1007\/s00296-014-3139-3","journal-title":"Rheumatol Int"},{"key":"9106_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204698","author":"C Beyer","year":"2014","unstructured":"Beyer C, Zampetaki A, Lin N-Y et al (2014) Signature of circulating microRNAs in osteoarthritis. Ann Rheum Dis. doi: 10.1136\/annrheumdis-2013-204698","journal-title":"Ann Rheum Dis"},{"key":"9106_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.neuron.2014.02.011","volume":"82","author":"C-K Park","year":"2014","unstructured":"Park C-K, Xu Z-Z, Berta T et al (2014) Extracellular microRNAs activate nociceptor neurons to elicit pain via TLR7 and TRPA1. Neuron 82:47\u201354. doi: 10.1016\/j.neuron.2014.02.011","journal-title":"Neuron"},{"key":"9106_CR17","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1378\/chest.117.4.1162","volume":"117","author":"S Opal","year":"2000","unstructured":"Opal S, Depalo V (2000) Anti-inflammatory cytokines. Chest J 117:1162\u20131172","journal-title":"Chest J"},{"key":"9106_CR18","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/ana.410280213","volume":"28","author":"PJ Goadsby","year":"1990","unstructured":"Goadsby PJ, Edvinsson L, Ekman R (1990) Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 28:183\u2013187. doi: 10.1002\/ana.410280213","journal-title":"Ann Neurol"},{"key":"9106_CR19","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1111\/j.1526-4610.2005.00263.x","volume":"45","author":"O Papandreou","year":"2005","unstructured":"Papandreou O, Soldatou A, Tsitsika A et al (2005) Serum S100beta protein in children with acute recurrent headache: a potentially useful marker for migraine. Headache 45:1313\u20131316. doi: 10.1111\/j.1526-4610.2005.00263.x","journal-title":"Headache"},{"key":"9106_CR20","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1097\/WCO.0b013e328360864b","volume":"26","author":"M Antonova","year":"2013","unstructured":"Antonova M, Wienecke T, Olesen J, Ashina M (2013) Prostaglandins in migraine: update. Curr Opin Neurol 26:269\u2013275. doi: 10.1097\/WCO.0b013e328360864b","journal-title":"Curr Opin Neurol"},{"key":"9106_CR21","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1111\/j.1468-2982.2007.01476.x","volume":"27","author":"E Hamel","year":"2007","unstructured":"Hamel E (2007) Serotonin and migraine: biology and clinical implications. Cephalalgia 27:1293\u20131300. doi: 10.1111\/j.1468-2982.2007.01476.x","journal-title":"Cephalalgia"},{"key":"9106_CR22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.2174\/187152707781387279","volume":"6","author":"M Vikelis","year":"2007","unstructured":"Vikelis M, Mitsikostas DD (2007) The role of glutamate and its receptors in migraine. CNS Neurol Disord Drug Targets 6:251\u2013257","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"9106_CR23","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3389\/fphys.2014.00078","volume":"5","author":"D Sarrouilhe","year":"2014","unstructured":"Sarrouilhe D, Dejean C, Mesnil M (2014) Involvement of gap junction channels in the pathophysiology of migraine with aura. Front Physiol 5:78. doi: 10.3389\/fphys.2014.00078","journal-title":"Front Physiol"},{"key":"9106_CR24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.20452\/pamw.1093","volume":"121","author":"T Staszel","year":"2011","unstructured":"Staszel T, Zapa\u0142a B, Polus A et al (2011) Role of microRNAs in endothelial cell pathophysiology. Pol Arch Med Wewn 121:361\u2013366","journal-title":"Pol Arch Med Wewn"},{"key":"9106_CR25","doi-asserted-by":"publisher","first-page":"978","DOI":"10.2337\/db09-0881","volume":"59","author":"E Roggli","year":"2010","unstructured":"Roggli E, Britan A, Gattesco S et al (2010) Involvement of microRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes 59:978\u2013986. doi: 10.2337\/db09-0881","journal-title":"Diabetes"},{"key":"9106_CR26","doi-asserted-by":"publisher","first-page":"712","DOI":"10.1261\/rna.036863.112","volume":"19","author":"KL Burgos","year":"2013","unstructured":"Burgos KL, Javaherian A, Bomprezzi R et al (2013) Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing. RNA 19:712\u2013722. doi: 10.1261\/rna.036863.112","journal-title":"RNA"},{"key":"9106_CR27","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.3760\/cma.j.issn. 0366-6999.2010.18.012","volume":"123","author":"H-M Gao","year":"2010","unstructured":"Gao H-M, Li L, Zhang K-L et al (2010) Impact of migraine attacks on the blood-brain barrier. Chin Med J (Engl) 123:2559\u20132561. doi: 10.3760\/cma.j.issn. 0366-6999.2010.18.012","journal-title":"Chin Med J (Engl)"},{"key":"9106_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/1744-8069-5-43","volume":"5","author":"A Capuano","year":"2009","unstructured":"Capuano A, De Corato A, Lisi L et al (2009) Proinflammatory-activated trigeminal satellite cells promote neuronal sensitization: relevance for migraine pathology. Mol Pain 5:43. doi: 10.1186\/1744-8069-5-43","journal-title":"Mol Pain"},{"key":"9106_CR29","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0140-6736(77)91262-4","volume":"1","author":"AM Harper","year":"1977","unstructured":"Harper AM, MacKenzie ET, McCulloch J, Pickard JD (1977) Migraine and the blood-brain barrier. Lancet 1:1034\u20131036","journal-title":"Lancet"},{"key":"9106_CR30","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s10194-008-0011-4","volume":"9","author":"AS Link","year":"2008","unstructured":"Link AS, Kuris A, Edvinsson L (2008) Treatment of migraine attacks based on the interaction with the trigemino-cerebrovascular system. J Headache Pain 9:5\u201312. doi: 10.1007\/s10194-008-0011-4","journal-title":"J Headache Pain"},{"key":"9106_CR31","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1111\/j.1468-2982.2008.01675.x","volume":"28","author":"L Edvinsson","year":"2008","unstructured":"Edvinsson L, Tfelt-Hansen P (2008) The blood-brain barrier in migraine treatment. Cephalalgia 28:1245\u20131258. doi: 10.1111\/j.1468-2982.2008.01675.x","journal-title":"Cephalalgia"},{"key":"9106_CR32","unstructured":"Olesen J, Tfelt-Hansen P, Welc MA, et al. (2005) The headaches (3rd edition),\u00a0J\u00fcrgen Sandk\u00fchler, Chapter 11, Inhibition\u00a0and facilitation of nociception."},{"key":"9106_CR33","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1136\/bmj.3.5982.516","volume":"3","author":"KM Welch","year":"1975","unstructured":"Welch KM, Chabi E, Bartosh K et al (1975) Cerebrospinal fluid gamma aminobutyric acid levels in migraine. Br Med J 3:516\u2013517","journal-title":"Br Med J"},{"key":"9106_CR34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1046\/j.1526-4610.1996.3602101.x","volume":"36","author":"H Marukawa","year":"1996","unstructured":"Marukawa H, Shimomura T, Takahashi K (1996) Salivary substance P, 5-hydroxytryptamine, and gamma-aminobutyric acid levels in migraine and tension-type headache. Headache 36:100\u2013104","journal-title":"Headache"},{"key":"9106_CR35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1046\/j.1468-2982.1992.1202081.x","volume":"12","author":"R Hering","year":"1992","unstructured":"Hering R, Kuritzky A (1992) Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 12:81\u201384","journal-title":"Cephalalgia"},{"key":"9106_CR36","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010609","volume":"6","author":"M Linde","year":"2013","unstructured":"Linde M, Mulleners WM, Chronicle EP, McCrory DC (2013) Gabapentin or pregabalin for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev 6, CD010609. doi: 10.1002\/14651858.CD010609","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12035-015-9106-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9106-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-015-9106-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T22:15:14Z","timestamp":1747520114000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12035-015-9106-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,2,1]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["9106"],"URL":"https:\/\/doi.org\/10.1007\/s12035-015-9106-5","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,2,1]]}}}